Penserra Capital Management’s Medpace MEDP Stock Holding History

Penserra Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-988	Closed	-$507K	–	1113
2025 Q3	$507K	Buy	+988	New	+$431K	0.01%	573
2023 Q3	–	Sell	-4,460	Closed	-$1.07M	–	1320
2023 Q2	$1.07M	Buy	+4,460	New	+$926K	0.02%	366
2021 Q4	–	Sell	-820	Closed	-$155K	–	1472
2021 Q3	$155K	Sell	820 -3,670	-82%	-$669K	﹤0.01%	665
2021 Q2	$792K	Buy	4,490 +3,685	+458%	+$636K	0.01%	436
2021 Q1	$132K	Sell	805 -15	-2%	-$2.29K	﹤0.01%	653
2020 Q4	$114K	Buy	820 +518	+172%	+$65.3K	﹤0.01%	593
2020 Q3	$33K	Buy	+302	New	+$34.9K	﹤0.01%	672
2019 Q4	–	Sell	-8,181	Closed	-$687K	–	948
2019 Q3	$687K	Buy	+8,181	New	+$618K	0.06%	267
2019 Q1	–	Sell	-215,145	Closed	-$11.4M	–	769
2018 Q4	$11.4M	Sell	215,145 -72,904	-25%	-$4M	1.11%	20
2018 Q3	$17.3M	Buy	+288,049	New	+$15.8M	1.06%	34

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Penserra Capital Management's MEDP Position: Q4 2025 in Review

Penserra Capital Management sold out of Medpace (MEDP) in Q4 2025, closing a stake of 988 shares — an estimated $507K sold.

Penserra Capital Management first reported a position in MEDP in Q3 2018 and held it in 10 quarters. The position peaked at $17.3M in Q3 2018. 785 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

Penserra Capital Management reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
Penserra Capital Management sold 988 Medpace shares in Q4 2025, an estimated $507K.
Penserra Capital Management first reported a position in Medpace in Q3 2018 and held it in 10 quarters.
Penserra Capital Management's Medpace position peaked at $17.3M in Q3 2018.
785 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Penserra Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.